NTR revenueFY2025$26.89B
- FY YoY
- +3.5%
- 5Y CAGR
- +5.2%
NTR revenue was $26.89B for fiscal 2025 (ended Dec 31, 2025), up 3.5% from fiscal 2024. Compound annual growth was +5.2% over 5 years. It rose in 6 of the last 8 fiscal years.
Nutrien Ltd. (NTR) financials
For fiscal 2025 (ended Dec 31, 2025), Nutrien Ltd. reported $26.89B of revenue and $2.27B of net income.
- Revenue, FY2025
- $26.89B
- Revenue growth, YoY
- +3.5%
- Net income, FY2025
- $2.27B
- Net income growth, YoY
- +236.4%
- Net margin
- 8.4%
- Free cash flow, FY2025
- $2.13B
- EPS, diluted, FY2025
- $4.66
- EPS growth, YoY
- +242.6%
- Cash
- $701.00M
- Total debt
- $9.35B
- P/E
- 14.95
- P/S
- 1.26
- Market cap
- $33.89B
FY2017FY2025
FY2017FY2025
FY2017FY2025
NTR revenue and earnings growth
NTR net incomeFY2025$2.27B
- FY YoY
- +236.4%
- 5Y CAGR
- +37.6%
NTR net income was $2.27B for fiscal 2025 (ended Dec 31, 2025), up 236.4% from fiscal 2024. Compound annual growth was +37.6% over 5 years. It rose in 4 of the last 8 fiscal years.
NTR EPSFY2025$4.66
- FY YoY
- +242.6%
- 5Y CAGR
- +41.9%
NTR diluted EPS was $4.66 for fiscal 2025 (ended Dec 31, 2025), up 242.6% from fiscal 2024. Compound annual growth was +41.9% over 5 years.
NTR free cash flowFY2025$2.13B
- FY YoY
- +40.7%
- 5Y CAGR
- +2.3%
NTR free cash flow was $2.13B for fiscal 2025 (ended Dec 31, 2025), up 40.7% from fiscal 2024. Compound annual growth was +2.3% over 5 years. It rose in 5 of the last 8 fiscal years.
Income statement
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $26.89B | $25.97B | $29.06B | $37.88B | $27.71B | $20.91B | $20.08B | $19.64B | $4.55B |
| Cost of revenue | $17.60B | $17.49B | $19.61B | $21.59B | $17.45B | $14.81B | $13.81B | $13.38B | $3.32B |
| Gross profit | $8.35B | $7.53B | $8.47B | $15.42B | $9.41B | $5.24B | $5.50B | $5.39B | $694.00M |
| Selling, general and admin | $600.00M | $644.00M | $626.00M | $565.00M | $477.00M | $429.00M | $404.00M | $423.00M | $185.00M |
| Operating income | $3.74B | $1.86B | $2.75B | $10.81B | $4.78B | $902.00M | $1.86B | $414.00M | $209.00M |
| Interest expense | $746.00M | $765.00M | $797.00M | $521.00M | $492.00M | $520.00M | $554.00M | $538.00M | $238.00M |
| Pre-tax income | $3.05B | $1.14B | $1.95B | $10.25B | $4.17B | $382.00M | $1.31B | -$124.00M | -$29.00M |
| Income tax | $752.00M | $436.00M | $670.00M | $2.56B | $989.00M | -$77.00M | $316.00M | -$93.00M | -$183.00M |
| Net income | $2.27B | $674.00M | $1.26B | $7.66B | $3.15B | $459.00M | $992.00M | $3.57B | $327.00M |
| EPS, basic | $4.66 | $1.36 | $2.53 | $14.22 | $5.53 | $0.81 | $1.70 | $5.72 | $0.39 |
| EPS, diluted | $4.66 | $1.36 | $2.53 | $14.18 | $5.52 | $0.81 | $1.70 | $5.72 | $0.39 |
| Diluted shares | 486.5M | 494.4M | 497.0M | 540.0M | 571.3M | 569.7M | 583.1M | 624.9M | 840.3M |
Balance sheet
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $701.00M | $853.00M | $941.00M | $901.00M | $499.00M | $1.45B | $671.00M | $2.31B | $116.00M |
| Receivables | $5.67B | $5.39B | $5.40B | $6.19B | $5.37B | $3.63B | $3.54B | $3.34B | $489.00M |
| Inventory | $6.98B | $6.15B | $6.34B | $7.63B | $6.33B | $4.93B | $4.97B | $4.92B | $788.00M |
| Current assets | $14.75B | $13.79B | $14.17B | $16.34B | $13.85B | $11.47B | $10.66B | $11.66B | $3.32B |
| Goodwill | $12.14B | $12.04B | $12.11B | $12.37B | $12.22B | $12.20B | $11.99B | $11.43B | $97.00M |
| Total assets | $52.30B | $51.84B | $52.75B | $54.59B | $49.95B | $47.19B | $46.80B | $45.50B | $17.00B |
| Current liabilities | $11.04B | $12.04B | $12.12B | $14.28B | $12.44B | $8.48B | $9.13B | $8.34B | $1.60B |
| Long-term debt | $9.35B | $8.88B | $8.91B | $8.04B | $7.52B | $10.05B | $8.55B | $7.58B | $3.71B |
| Total debt | $9.35B | $8.88B | $8.91B | $8.04B | $7.52B | $10.05B | $8.55B | $7.58B | $3.71B |
| Total liabilities | $26.94B | $27.40B | $27.55B | $28.72B | $26.25B | $24.79B | $23.93B | $21.08B | $8.70B |
| Shareholders' equity | $25.32B | $24.41B | $25.20B | $25.86B | $23.70B | $22.40B | $22.91B | $24.43B | $8.30B |
Cash flow
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $4.01B | $3.54B | $5.07B | $8.11B | $3.89B | $3.32B | $3.67B | $2.05B | $1.23B |
| Capital expenditures | $1.88B | $2.02B | $2.42B | $2.25B | $1.78B | $1.42B | $1.73B | $1.41B | $651.00M |
| Free cash flow | $2.13B | $1.51B | $2.65B | $5.86B | $2.11B | $1.90B | $1.94B | $647.00M | $574.00M |
| Investing cash flow | -$1.37B | -$2.13B | -$2.96B | -$2.90B | -$1.81B | -$1.20B | -$2.80B | $3.89B | -$652.00M |
| Financing cash flow | -$2.82B | -$1.45B | -$2.06B | -$4.73B | -$3.00B | -$1.34B | -$2.48B | -$3.71B | -$489.00M |
| Dividends paid | $1.06B | $1.06B | $1.03B | $1.03B | $1.04B | $1.03B | $1.02B | $952.00M | $330.00M |
| Share repurchases | $551.00M | $184.00M | $1.05B | $4.52B | $1.03B | $160.00M | $1.93B | $1.80B | - |
| Stock-based compensation | $163.00M | $37.00M | -$14.00M | $63.00M | $198.00M | $69.00M | $104.00M | $116.00M | $11.00M |
| Depreciation and amortization | $2.37B | $2.34B | $2.17B | $2.01B | $1.95B | $1.99B | $1.80B | $1.59B | $692.00M |
Key ratios
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue growth, YoY | 3.5% | -10.6% | -23.3% | 36.7% | 32.5% | 4.1% | 2.3% | 331.8% | - |
| Net income growth, YoY | 236.4% | -46.4% | -83.6% | 142.9% | 586.9% | -53.7% | -72.2% | 992.7% | - |
| EPS growth, YoY | 242.6% | -46.2% | -82.2% | 156.9% | 581.5% | -52.4% | -70.3% | 1366.7% | - |
| Gross margin | 31.0% | 29.0% | 29.2% | 40.7% | 34.0% | 25.1% | 27.4% | 27.5% | 15.3% |
| Operating margin | 13.9% | 7.1% | 9.4% | 28.5% | 17.3% | 4.3% | 9.3% | 2.1% | 4.6% |
| Net margin | 8.4% | 2.6% | 4.3% | 20.2% | 11.4% | 2.2% | 4.9% | 18.2% | 7.2% |
| Free cash flow margin | 7.9% | 5.8% | 9.1% | 15.5% | 7.6% | 9.1% | 9.6% | 3.3% | 12.6% |
| Return on equity | 9.0% | 2.8% | 5.0% | 29.6% | 13.3% | 2.0% | 4.3% | 14.6% | 3.9% |
| Return on assets | 4.3% | 1.3% | 2.4% | 14.0% | 6.3% | 1.0% | 2.1% | 7.9% | 1.9% |
| Current ratio | 1.34 | 1.15 | 1.17 | 1.14 | 1.11 | 1.35 | 1.17 | 1.40 | 2.07 |
| Debt to equity | 0.37 | 0.36 | 0.35 | 0.31 | 0.32 | 0.45 | 0.37 | 0.31 | 0.45 |
Source: XBRL data Nutrien Ltd. files with the SEC, latest filing dated Feb 27, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.
Per-share figures are as filed. The filings show no stock split in these periods.
EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.
Foreign private issuers file annual reports with the SEC, so there are no quarterly statements here.
NTR peers
| Company | Revenue | Growth | Net income | Net margin | Market cap |
|---|---|---|---|---|---|
| NTR | $26.89B | +3.5% | $2.27B | 8.4% | $33.89B |
| CF | $7.94B | +17.9% | $2.18B | 27.5% | $18.07B |
| MOS | $11.90B | +0.0% | -$1.12B | -9.4% | $7.11B |
| ICL | $7.15B | +4.6% | $226.00M | 3.2% | $6.03B |
| SMG | $3.48B | +4.6% | $73.90M | 2.1% | $3.77B |
| UAN | $659.46M | +7.3% | $106.41M | 16.1% | $1.16B |
| CBUS | $4.35M | -10.3% | -$98.19M | -2258.9% | $90.2M |
| AVD | $510.32M | -3.5% | -$54.58M | -10.7% | $28.4M |
| BIOX | $238.28M | -17.7% | -$263.94M | -110.8% | $14.7M |
NTR FAQ
9 questionsWhat is NTR revenue?
Nutrien Ltd. (NTR) reported $26.89B of revenue for fiscal 2025 (ended Dec 31, 2025). That is up 3.5% from the year before.Is NTR profitable?
Yes. Nutrien Ltd. earned $2.27B in net income for fiscal 2025 (ended Dec 31, 2025), a net margin of 8.4%.How much cash and debt does NTR have?
Nutrien Ltd. reported $701.00M in cash and cash equivalents and $9.35B of debt on its most recent balance sheet in SEC filings.How fast is NTR revenue growing?
Nutrien Ltd.'s revenue changed +3.5% in fiscal 2025, to $26.89B. Its compound annual growth rate was +5.2% over 5 years.What is NTR gross margin?
Nutrien Ltd.'s gross profit was $8.35B on $26.89B of revenue for fiscal 2025 (ended Dec 31, 2025), a gross margin of 31.0%.What is NTR free cash flow?
Nutrien Ltd. generated $2.13B of free cash flow for fiscal 2025 (ended Dec 31, 2025), which is operating cash flow of $4.01B less capital expenditures.What is NTR earnings per share?
Diluted earnings per share were $4.66 for fiscal 2025 (ended Dec 31, 2025), from SEC filings, restated for any stock split those filings show.When did NTR last report financial results?
The latest statements here come from Nutrien Ltd.'s 40-F filed on Feb 27, 2026, covering the period ended Dec 31, 2025.Where does this NTR financial data come from?
Quantisnow builds these statements from the structured XBRL data Nutrien Ltd. files with the SEC. It is provided for information only and is not investment advice.